Trials / Completed
CompletedNCT01713413
Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases
Effects of an Oxymizer Versus Conventional Nasal Cannula on Endurance Time in Patients With Chronic Obstructive Pulmonary Disease IV (COPD) or Interstitial Lung Disease (ILD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Schön Klinik Berchtesgadener Land · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The Oxymizer pendant® is a special oxygen cannula that can be used to supply high flow long term oxygen therapy. It is compatible with a wide variety of oxygen sources. In a reservoir, the Oxymizer® stores pure oxygen so that the concentration of inhaled oxygen is increased. The aim of this study is to investigate the potential benefit of the Oxymizer® with regard to the blood oxygenation during exercise testing. Given that the "endurance time" is very sensitive for little changes in exercise capacity, this test will be used to show the difference between the Oxymizer® and a conventional nasal cannula regarding exercise duration at 70% of peak Watt and oxygenation. The tests will be accompanied by blood gas analysis, partial pressure of carbon dioxide and heart rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Oxymizer | Using first the Oxymizer and 24 h later the conventional nasal cannula. |
| DEVICE | conventional nasal cannula | Using first the conventional nasal cannula and 24h later the Oxymizer |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-02-01
- Completion
- 2014-03-01
- First posted
- 2012-10-24
- Last updated
- 2014-04-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01713413. Inclusion in this directory is not an endorsement.